William Gmeiner

Professor

Atrium Health Wake Forest Baptist

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

William Gmeiner is a Professor at Atrium Health Wake Forest Baptist in the United States. His research primarily focuses on therapeutic strategies for colorectal cancer, particularly exploring the efficacy of fluoropyrimidine drugs and novel nanodelivery systems. His recent publications discuss various aspects of colorectal cancer treatment, including resistance mechanisms and the development of improved therapeutic approaches.

Articles (8)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

Sezgin Kiren

Associate Professor

Winston-Salem State University

UNITED STATES

View details

Lance Miller

Professor

Wake Forest School of Medicine

UNITED STATES

View details

Ralph Dagostino Jr

Professor

Wake Forest School of Medicine

UNITED STATES

View details

Jennifer Roth

Broad Institute

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

William Gmeiner

Research Interests

Explore related searches

Contact this professor

About

Articles (8)

CF10 Displayed Improved Activity Relative to 5-FU in a Mouse CRLM Model Under Conditions of Physiological Folate

CF10/LV overcomes acquired resistance to 5-FU/LV in colorectal cancer cells through downregulation of the c-Myc/ABCB5 axis

Review of Prodrug and Nanodelivery Strategies to Improve the Treatment of Colorectal Cancer with Fluoropyrimidine Drugs

Enhanced Therapeutic Efficacy of the Nanoscale Fluoropyrimidine Polymer CF10 in a Rat Colorectal Cancer Liver Metastasis Model

Recent Advances in Therapeutic Strategies to Improve Colorectal Cancer Treatment

Dysregulated Pyrimidine Biosynthesis Contributes to 5-FU Resistance in SCLC Patient-Derived Organoids but Response to a Novel Polymeric Fluoropyrimidine, CF10.

Chemistry of Fluorinated Pyrimidines in the Era of Personalized Medicine

Fluoropyrimidine Modulation of the Anti-Tumor Immune Response―Prospects for Improved Colorectal Cancer Treatment

Collaborators (4)

Sezgin Kiren

Lance Miller

Ralph Dagostino Jr

Jennifer Roth

Make your next move.